This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
As you probably know by now, my ears perk up when I hear of a new way to vet the...
Axsome Therapeutics said the lower dose of its sleep disorder drug Sunosi met th...
GSK won approval on Wednesday for a new type of oral antibiotic to treat uncompl...
Turn Biotechnologies, a startup developing mRNA therapies to wind back the clock...
WuXi Biologics attributed a 32.5% increase in North American revenue last year t...
Kezar reported new data Tuesday morning from a small Phase 2a study in autoimmun...
Plus, news about Relmada Therapeutics and Mural Oncology: Cassava Sciences f...
Seven years into its existence, Character Biosciences is ready to enter the clin...
GSK is teaming up with a pair of UK-based research bodies to conduct a “real wor...
GSK is teaming up with a pair of UK-based research bodies to conduct a “real wor...
Merck has struck a licensing deal for a cardiovascular drug with Jiangsu Hengrui...
The flurry of immunology biotech launches continues. Boston-based Hillstar B...
President Donald Trump has nominated acting CDC director Susan Monarez to lead t...
President Donald Trump reiterated his plans to “at some point" put tariffs on ph...
AbbVie has accused a Genmab subsidiary of stealing trade secrets to build a pote...
Incorporating disease transmission data into vaccine trial designs could add to ...